apocodeine has been researched along with Parkinson Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coudoré, F; Durif, F; Eschalier, A; Libert, F; Richard, D | 1 |
Bodde, HE; Danhof, M; Gubbens-Stibbe, JM; Kruger, P; van der Geest, R; van Laar, T | 1 |
2 other study(ies) available for apocodeine and Parkinson Disease
Article | Year |
---|---|
Development of a gas chromatographic/mass spectrometric method to quantify R(-)-apomorphine, R(-)-apocodeine and R(-)-norapomorphine in human plasma and urine.
Topics: Apomorphine; Catechol O-Methyltransferase Inhibitors; Catechols; Gas Chromatography-Mass Spectrometry; Humans; Nitriles; Parkinson Disease; Reproducibility of Results | 2005 |
Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's disease.
Topics: Acetic Acid; Antiparkinson Agents; Apomorphine; Chromatography, High Pressure Liquid; Circadian Rhythm; Glucuronates; Glucuronic Acid; Glucuronidase; Humans; Hydrolysis; Infusions, Intravenous; Linear Models; Male; Parkinson Disease; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism; Sulfatases; Sulfates; Time Factors | 1997 |